2-Methyl-4-(Trifluoromethyl)Thiazole-5-Carboxylic Acid

In bulk thifluzamide technical concentrate (TC) production, 2-methyl-4-(trifluoromethyl)thiazole-5-carboxylic acid is first dried in a double-cone vacuum dryer operating at 55–60 °C and ≤−0.095 MPa until the moisture content drops below 0.05 % (Karl Fischer titration, ASTM E203). The dried acid is charged into a glass-lined reactor fitted with a reflux condenser and a caustic scrubber loop designed to handle an initial SO₂/HCl evolution rate of up to 120 m³/h. Thionyl chloride is metered in at a molar ratio of 1.0:1.15 (acid:SOC₂) while the batch is held at 78–82 °C; the endpoint is confirmed by in-line FTIR tracking the disappearance of the carbonyl stretch at 1685 cm⁻¹. The resulting 2-methyl-4-(trifluoromethyl)thiazole-5-carbonyl chloride solution is then transferred under nitrogen to a second glass-lined vessel where it is added dropwise to a dichloromethane solution of 2′,6′-dibromo-4-trifluoromethoxyaniline and triethylamine at −5 to 0 °C. Overdosing the acid beyond 1.03 molar equivalents relative to the amine, or allowing the condensation temperature to exceed 5 °C, causes a measurable increase in the symmetrical urea by-product (quantified by HPLC, CIPAC MT 580) that cannot be removed by recrystallization alone. The crude thifluzamide cake is washed with deionized water until the washings register a conductivity ≤50 μS/cm and is then vacuum-dried at 70 °C to yield a white-to-pale-yellow crystalline solid. The final TC must conform to GB 22610-2008: purity ≥96.0 %, loss on drying ≤0.5 %, acidity (as H₂SO₄) ≤0.2 %, and insolubles in acetone ≤0.2 %. The acid intermediate itself is registered under EU REACH Regulation (EC) No. 1907/2006 as a transported isolated intermediate, and the site-level exposure scenario requires local exhaust ventilation maintaining a workplace airborne concentration below 0.1 mg/m³ (8-h TWA).

连续流酰氯化过程中，换热效率对2-甲基-4-三氟甲基噻唑-5-酰氯分解速率的限制

Microchannel reactor systems processing 2-methyl-4-(trifluoromethyl)thiazole-5-carboxylic acid encounter a narrow thermal processing window because the acyl chloride product begins to exothermically decompose at bulk-fluid temperatures above 42 °C, releasing HF and forming a dark intractable tar that fouls the reactor surface. Bench-scale differential scanning calorimetry (DSC, ASTM E537) of a representative mixture—acid (1.0 mol), thionyl chloride (1.1 mol), and tetrahydrofuran (5.0 vol)—shows an onset exotherm at 38 °C and a peak at 51 °C with an energy release of −285 J/g. In a SiC-based microreactor with a characteristic channel dimension of 0.8 mm and a heat-transfer coefficient exceeding 2000 W/m²·K, the residence time is restricted to 18–25 s at a setpoint of 35 ± 1 °C to hold conversion above 99.5 % while limiting the decomposition impurity to ≤0.12 area-% (HPLC, 220 nm). The recipe on a continuous skid uses a 1.0:1.08 molar feed ratio of acid to thionyl chloride, delivered by syringe pumps fitted with Hastelloy C-276 wetted parts; the acid is dissolved in anhydrous THF (water spec. ≤50 ppm, NIR monitoring) at 0.8 M. Downstream, the crude acyl chloride stream is immediately quenched into a pre-cooled dichloromethane-amine solution to produce thifluzamide without intermediate isolation. A production bottleneck arises from microchannel blockage when the acid feed contains fine particulate above 5 µm (caused by incomplete dissolution or moisture-induced precipitation), necessitating an in-line 2 µm PTFE depth filter and daily alkaline CIP (clean-in-place) cycles with 5 % sodium hydroxide at 60 °C. The process is operated under an ISO 9001:2015 quality management framework with PAT-driven real-time release testing; residual thionyl chloride in the quenched organic phase must fall below 10 ppm before phase splitting to meet waste-stream COD limits of 800 mg/L (EU Industrial Emissions Directive 2010/75/EU).

When the carboxylic acid is employed as the starting material for synthesizing thifluzamide-related impurity reference standards (e.g., the des-trifluoromethoxy analogue or the 5-carboxamide derivative), the purity specification is elevated from the technical-grade benchmark of 97.0 % to a pharmaceutical-grade requirement of ≥99.8 % (HPLC, CIPAC 420/ICH Q2(R1)). The crude acid is recrystallized twice from an ethyl acetate/n-heptane mixture (3:1 v/v), air-dried, and then sublimed under reduced pressure (10⁻³ mbar, 85 °C bath) in a short-path glass apparatus. Obtaining a certified reference material (CRM) compliant with ISO 17034:2016 necessitates three independent batch analyses demonstrating an inter-batch purity RSD ≤0.10 %, water content ≤0.02 % (ASTM E1064), and residual solvent levels ≤500 ppm (GC-headspace, ISO 17025-accredited method). The downstream preparation of the thifluzamide impurity D standard (the free acid of the active ingredient’s hydrolysis product) uses a slurry of the purified acid, 1-hydroxybenzotriazole (HOBt, 1.2 eq.), and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC, 1.3 eq.) in dry dimethylformamide at 0 °C; the batch is agitated by an overhead stirrer with a PTFE paddle at 180 rpm for 6 h. The terminal product, a white lyophilized powder sealed under argon in amber vials, carries a certified value of 99.5 % ± 0.3 % (k=2) and is used to calibrate LC-MS/MS systems in pesticide residue enforcement programs (EU SANTE/11312/2021).

What Makes the GC-FID Derivatization of Residual 2-Methyl-4-(Trifluoromethyl)Thiazole-5-Carboxylic Acid in Formulated Products Particularly Irreproducible?

Direct gas-chromatographic quantification of the free acid in formulated thifluzamide SC or WG batches is hampered by strong active-site adsorption on the column inlet, yielding recovery rates as low as 42–55 % when non-derivatized splitless injection is attempted. A validated silylation protocol involves extracting the acid from an acidified formulation slurry (pH 2.0, 0.1 M HCl) into methyl tert-butyl ether, evaporating to dryness under a gentle nitrogen stream, and reacting the residue with 100 µL of BSTFA + 1 % TMCS at 70 °C for 45 min in a sealed Reacti-Vap vial. Even with silanized glass inserts and a retention gap of 5 m × 0.53 mm deactivated fused silica, the within-lab reproducibility (RSD) drifts to 12 % unless the injection port liner is replaced after every 20 injections. The derivatization efficiency exhibits a matrix-dependent quenching effect: lignosulfonate dispersants (common in WG formulations) reduce the silylation yield by 15–20 %, requiring matrix-matched calibration as stipulated in SANCO/12571/2013. The limit of quantification for the free acid in a 24 % w/v SC is set at 0.015 % w/w relative to the active ingredient, monitored by a QC laboratory accredited to ISO/IEC 17025:2017 using a GC-FID system equipped with an Agilent DB-5 column (30 m × 0.25 mm, 0.25 µm) and a PTV inlet programmed from 60 °C to 300 °C at 15 °C/s.

在制备240 g/L噻呋酰胺悬浮剂时，原药中游离酸对研磨粘度与奥氏熟化的诱发机制

Thifluzamide TC containing residual 2-methyl-4-(trifluoromethyl)thiazole-5-carboxylic acid at levels ≥0.25 % w/w acts as an ionic surfactant in aqueous milling, causing a sudden drop in zeta potential (measured on a Malvern Zetasizer Nano ZS) from −45 mV to −28 mV at pH 6.5, which triggers catastrophic viscosity increase from 380 mPa·s to >1200 mPa·s (Brookfield LV, spindle #3, 30 rpm) inside the horizontal bead mill. The formulation recipe targets a thifluzamide loading of 24 % w/v, so a 0.25 % acid contamination in the TC translates to approximately 60 mg/L free acid in the millbase. During bead milling with 0.6–0.8 mm yttria-stabilized zirconia beads at a fill ratio of 80 % and a tip speed of 12 m/s, Ostwald ripening accelerates: particle-size distribution broadens from D₅₀ = 0.9 µm to 2.3 µm within 4 h of post-milling storage, as tracked by a Malvern Mastersizer 3000. Process control therefore enforces an incoming TC specification of free acid ≤0.10 % by HPLC (CIPAC MT 580), and the pre-milling slurry is adjusted to pH 7.8 ± 0.2 with a 10 % sodium hydroxide solution to ion-pair the residual acid. The finished suspension concentrates must pass a wet-sieving test over a 75 µm screen with ≤0.1 % residue (CIPAC MT 36.3) and a pourability test (CIPAC MT 148.1) with ≤3.5 % residue after rinsing. The packaged product is stored under ASTM D4169-22 distribution-cycle simulation and must retain a D₉₀ ≤5.0 µm after two-week accelerated aging at 54 °C (CIPAC MT 46.3).

Loading 2-methyl-4-(trifluoromethyl)thiazole-5-carboxylic acid onto Wang resin via an active-ester strategy is a standard entry point for the parallel synthesis of focused libraries of thiazole-5-carboxamides screened against succinate dehydrogenase (SDH) enzyme targets. The pre-swelled resin (loading 0.9 mmol/g) in DMF is treated with a solution of the acid (3.0 eq. relative to resin sites), diisopropylcarbodiimide (3.3 eq.), and HOBt (3.0 eq.) at 22 °C for 14 h; the coupling efficiency is monitored gravimetrically after cleaving a test aliquot, and batches are released when the loading reaches ≥0.80 mmol/g (nitrogen elemental analysis, ASTM D5291). The resin-bound acid is subsequently subjected to amide bond formation with an array of substituted aromatic and heterocyclic amines using HATU (2.5 eq.) and N,N-diisopropylethylamine (5.0 eq.) in NMP, followed by TFA cleavage, precipitation in cold diethyl ether, and preparative reversed-phase HPLC (C18, acetonitrile/water + 0.1 % TFA gradient). Hits emerging from a Ghose-Crippen-based virtual screen with ligand efficiencies ≥0.35 kcal/mol per heavy atom are resynthesized on 10 mmol scale in a jacketed laboratory reactor with an anchor stirrer and a circulating bath set to 0 °C. No GLP toxicology data is yet available for the majority of library members, so all operations are conducted under an ISO 10993-5:2018 extraction-condition risk framework with a zero-discharge solvent containment system. The end products, typically white to off-white solids with melting points spanning 135–218 °C, are provided as micronized powders (D₉₀<10 µm) for greenhouse trials targeting Phakopsora pachyrhizi (soybean rust) and Fusarium graminearum (head blight).